US 9937156
Modulation of MRTF-A activity in pathologic fibrosis and wound healing
granted A61KA61K31/42A61K45/06
Quick answer
US patent 9937156 (Modulation of MRTF-A activity in pathologic fibrosis and wound healing) held by The Board of Regents of the University of Texas System expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/42, A61K45/06, A61K9/06, A61K9/08